HealthDay on MSN18h
AI Improves Risk Prediction in Patients With Myelofibrosis Undergoing Allo-HCT
For patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (allo-HCT), machine learning (ML) ...
Takeda & Protagonist: Rusfertide Clinical Success Bolsters Investment Returns
Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.
The American Journal of Managed Care3d
Reducing Polycythemia Vera–Associated Thrombotic Risk Through Iron Regulation
In part 3 of a discussion with Andrew Kuykendall, MD, Moffitt Cancer Center, he talks of rusfertide’s ability to enable ...
The Daily Courier7d
To Your Good Health: New cell-free DNA testing not recommended for p. vera patient
I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer ...
Targeted Oncology7d
Ropeginterferon Alfa Reduces JAK2 Allele Burden Over Long Term in PV
Douglas A. Tremblay, MD, discusses the long-term data supporting ropeginterferon alfa-2b-njft as treatment in patients with polycythemia vera.
Press Enterprise Online8d
New cell-free DNA testing is not recommended for p. vera patient
I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? — M.N.
Oregonian8d
Dear Doctor: What type of person benefits most from the new cell-free DNA cancer testing?
DEAR DR. ROACH: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood test for cancer. Is it worthwhile? -- M.N. ANSWER: When screening patients ...
Dr. Roach: New cell-free DNA testing not recommended for p. vera patient
Dear Dr. Roach: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood ...
Sun Journal8d
New cell-free DNA testing not recommended for p. vera patient
Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 85 and healthy apart from polycythemia vera, for which I take aspirin. I was interested in the new blood ...
Verywell Health8d
8 Signs of a Dangerous Blood Clot
The signs of a dangerous blood clot can vary depending on its location. Some people may also not experience any symptoms.
Carlsbad’s Ionis strikes deal with Japanese pharma worth up to $940M
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.